The 2020 American Heart Association / American College of Cardiology guidelines for the diagnosis and treatment of patients with ypertrophic cardiomyopathy: what is new?
Автор: Budagaev Sergey A., Afanasyev Alexander V., Bogachev-prokophiev Alexander V., Zalesov Anton S., Ovcharov Michail A.
Журнал: Патология кровообращения и кардиохирургия @journal-meshalkin
Рубрика: Рекомендации
Статья в выпуске: 2 т.25, 2021 года.
Бесплатный доступ
On 22 December 2020, Circulation published the new American College of Cardiology / American Heart Association guidelines for the diagnosis and treatment of patients with hypertrophic cardiomyopathy. The most important guidelines were those concerning pharmacological and invasive methods of treating symptomatic patients with obstruction of the left ventricular outlet. Considering the most recent clinical studies, the indications for invasive methods of treatment have expanded to include septal myectomy and alcohol septal ablation. A separate section in the guidelines has been devoted to the management of non-obstructive hypertrophic cardiomyopathy with preserved left ventricular ejection fraction. The recommendations for patients with hypertrophic cardiomyopathy with atrial fibrillation, ventricular arrhythmias and severe heart failure have been revised.
Clinical practice guidelines, hypertrophic cardiomyopathy
Короткий адрес: https://sciup.org/142230782
IDR: 142230782 | DOI: 10.21688/1681-3472-2021-2-108-115